| Alyssa Hulthen, | |
|
150 N Miller Rd Ste 150a, Fairlawn, OH 44333-3713 | |
| (330) 867-2240 | |
| Not Available |
| Full Name | Alyssa Hulthen |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 150 N Miller Rd Ste 150a, Fairlawn, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174107809 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alyssa Hulthen, 1678 Hampton Knoll Dr, Akron, OH 44313-9159 Ph: (330) 241-1595 | Alyssa Hulthen, 150 N Miller Rd Ste 150a, Fairlawn, OH 44333-3713 Ph: (330) 867-2240 |
News Archive
For the eighth consecutive time, Rush University Medical Center has received an "A" for patient safety in a nationwide evaluation of hospitals by the Leapfrog Group. Rush has received an A, the top grade possible, each time the Leapfrog Group has rated hospitals since launching the organization's Hospital Safety Score in June 2012.
Research from the Oklahoma Medical Research Foundation reveals a new complexity to nerve cells in the brain that could affect future therapies aimed at altering mood and memory in humans.
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration for a new Clostridium difficile immunoassay named Premier C. difficile GDH.
A meta-analysis of approximately 80,000 individuals from 32 prospective studies was published in The Lancet on May 1, 2010. The data shows that elevated levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific inflammatory enzyme, are associated with an increased risk of coronary heart disease similar in magnitude to that with non-HDL cholesterol or systolic blood pressure.
A new study led by investigators from the University of Pittsburgh School of Medicine demonstrates that the process of necrosis, long thought to be a chaotic, irreversible pathway to cell death, may actually be triggered as part of a regulated response to stress by a powerful protein, SRP-6, that can potentially halt necrosis in its path.
› Verified 3 days ago
Mrs. Taylor Nicole Schell, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Rd Ste 150a, Fairlawn, OH 44333 Phone: 330-867-2240 Fax: 330-867-2245 | |
Kristen Lee Bever, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Rd Ste 150a, Fairlawn, OH 44333 Phone: 330-867-2240 Fax: 330-630-3198 | |
Isaac Sernoffsky, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Rd Ste 150a, Fairlawn, OH 44333 Phone: 330-867-2240 Fax: 330-630-3198 | |
Mrs. Becky Jo Dyer, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2645 Smith Rd, Fairlawn, OH 44333 Phone: 330-664-4991 | |
Kaitlin George, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Rd Ste 150a, Fairlawn, OH 44333 Phone: 330-867-2240 Fax: 330-630-3198 | |
Laura Ray, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3428 W Market St, Fairlawn, OH 44333 Phone: 330-668-4041 | |
Brenna Dupratt, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 N Miller Rd Ste 150a, Fairlawn, OH 44333 Phone: 330-867-2240 Fax: 330-630-3198 |